Primary myelofibrosis: 2013 update on diagnosis, risk‐stratification, and management
Disease overviewPrimary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by stem cell‐derived clonal myeloproliferation, abnormal cytokine expression, bone marrow fibrosis, anemia, splenomegaly, extramedullary hematopoiesis (EMH), constitutional symptoms, cachexia, leukemic progression, and shortened survival.
DiagnosisDiagnosis is based on bone marrow morphology. The presence of fibrosis, JAK2/MPL mutation, or +9/13q− cytogenetic abnormality is supportive but not essential for diagnosis. Prefibrotic PMF mimics essential thrombocythemia in its presentation and the distinction is prognostically relevant. Differential diagnosis of myelofibrosis should include chronic myeloid leukemia, myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.
Risk stratificationThe Dynamic International Prognostic Scoring System‐plus (DIPSS‐plus) prognostic model for PMF can be applied at any point during the disease course and uses eight independent predictors of inferior survival: age >65 years, hemoglobin <10 g/dL, leukocytes >25 × 109/L, circulating blasts ≥1%, constitutional symptoms, red cell transfusion dependency, platelet count <100 × 109/L, and unfavorable karyotype (i.e., complex karyotype or sole or two abnormalities that include +8, −7/7q−, i(17q), inv(3), −5/5q−, 12p−, or 11q23 rearrangement). The presence of 0, 1, “2 or 3,” and ≥4 adverse factors defines low, intermediate‐1, intermediate‐2,...
Source: American Journal of Hematology - Category: Hematology Authors: Ayalew Tefferi Tags: A Continuing Medical Education Series Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Anemia | Chronic Leukemia | Chronic Myeloid Leukaemia | Chronic Pain | Continuing Medical Education | Education | Hematology | Hypertension | Leukemia | Myelodysplastic Syndrome | Myeloproliferative Disorders | Pain | Pain Management | Pulmonary Hypertension | Splenectomy | Stem Cell Therapy | Stem Cells | Transplants | Universities & Medical Training